Ex vivo tissue perturbations coupled to single cell RNA-seq reveal multi-lineage cell circuit dynamics in human lung fibrogenesis
暂无分享,去创建一个
Malte D. Luecken | B. Kashani | H. Schiller | W. Wuyts | R. Hatz | F. Theis | M. Ansari | C. Mayr | G. Burgstaller | N. Kneidinger | E. Geeraerts | L. Sanière | L. D. De Sadeleer | M. Stoleriu | Yuexin Chen | Jeanine C. Pestoni | N. Lang | D. Porras-Gonzalez | M. Gerckens | Shuhong Zhou | Janine Gote-Schniering | L. Heumos | J. Behr | Lin Yang | R. C. Jentzsch | Vladimir A. Shitov | Ahmed Agami | Yuexin Chen | Vincent Anquetil | M. Wögrath | S. Zhou | A. Agami | M. Luecken | Laurens J. De Sadeleer | Malte D. Luecken | Vladimir A Shitov | Jeanine C. Pestoni
[1] G. Peltz,et al. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python , 2022, Bioinform..
[2] E. Morrisey,et al. Atf3 defines a population of pulmonary endothelial cells essential for lung regeneration , 2022, bioRxiv.
[3] C. Ruppert,et al. Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis. , 2022, American journal of respiratory and critical care medicine.
[4] P. Carmeliet,et al. The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution , 2022, Cardiovascular research.
[5] Mir Ali,et al. Transcriptional responses to injury of regenerative lung alveolar epithelium , 2022, iScience.
[6] C. Samakovlis,et al. Autocrine Sfrp1 inhibits lung fibroblast invasion during transition to injury induced myofibroblasts , 2022, bioRxiv.
[7] Malte D. Luecken,et al. An integrated cell atlas of the human lung in health and disease , 2022, bioRxiv.
[8] Yonghua Guo,et al. PD-1/PD-L1 inhibitor ameliorates silica-induced pulmonary fibrosis by maintaining systemic immune homeostasis. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] Michael I. Jordan,et al. A Python library for probabilistic analysis of single-cell omics data , 2022, Nature Biotechnology.
[10] Malte D. Luecken,et al. The discovAIR project: a roadmap towards the Human Lung Cell Atlas , 2022, European Respiratory Journal.
[11] M. Lindner,et al. Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics , 2021, Science advances.
[12] S. Ryter,et al. Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis. , 2021, Annual review of pathology.
[13] Fabian J Theis,et al. SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis , 2021, Cell.
[14] T. Nawrot,et al. Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis. , 2021, American journal of respiratory and critical care medicine.
[15] Tobias Pietzsch,et al. Labkit: Labeling and Segmentation Toolkit for Big Image Data , 2021, bioRxiv.
[16] Fabian J Theis,et al. Mapping single-cell data to reference atlases by transfer learning , 2021, Nature Biotechnology.
[17] Yongjin P. Park. Faculty Opinions recommendation of SCENIC: single-cell regulatory network inference and clustering. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[18] Fabian J Theis,et al. Machine learning for perturbational single-cell omics. , 2021, Cell systems.
[19] Zhe Wu,et al. Non-canonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis. , 2021, American journal of respiratory cell and molecular biology.
[20] Mark G. Jones,et al. Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis , 2021, bioRxiv.
[21] Timothy L. Tickle,et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.
[22] André F. Rendeiro,et al. A molecular single-cell lung atlas of lethal COVID-19 , 2021, Nature.
[23] K. Rabe,et al. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. , 2021, The Lancet. Respiratory medicine.
[24] Fabian J Theis,et al. Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers , 2021, EMBO molecular medicine.
[25] F. Prósper,et al. Notch3 Deficiency Attenuates Pulmonary Fibrosis and Impedes Lung Function Decline. , 2021, American journal of respiratory cell and molecular biology.
[26] A. Shilatifard,et al. Lung transplantation for patients with severe COVID-19 , 2020, Science Translational Medicine.
[27] W. Seeger,et al. Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg) , 2020, Journal of clinical medicine.
[28] D. Pe’er,et al. Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung , 2020, bioRxiv.
[29] Fabian J. Theis,et al. CellRank for directed single-cell fate mapping , 2020, Nature Methods.
[30] Xin Sun,et al. A transitional stem cell state in the lung , 2020, Nature Cell Biology.
[31] B. Koo,et al. Inflammatory Signals Induce AT2 Cell-Derived Damage-Associated Transient Progenitors that Mediate Alveolar Regeneration , 2020, Cell stem cell.
[32] Fabian J. Theis,et al. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis , 2020, Nature Communications.
[33] Jianhong Ou,et al. Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis , 2020, Nature Cell Biology.
[34] P. Wolters,et al. Human alveolar Type 2 epithelium transdifferentiates into metaplastic KRT5+ basal cells , 2020, bioRxiv.
[35] N. Kaminski,et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis , 2020, Nature Communications.
[36] A. Malik,et al. IL-1β Suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. , 2020, The Journal of clinical investigation.
[37] G. Verleden,et al. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study. , 2020, The Lancet. Respiratory medicine.
[38] Kerstin B. Meyer,et al. BBKNN: fast batch alignment of single cell transcriptomes , 2019, Bioinform..
[39] Leonard J. Foster,et al. Cell type prioritization in single-cell data , 2019, Nature Biotechnology.
[40] Y. Saeys,et al. NicheNet: modeling intercellular communication by linking ligands to target genes , 2019, Nature Methods.
[41] Ziv Bar-Joseph,et al. Transcriptional regulatory model of fibrosis progression in the human lung. , 2019, JCI insight.
[42] Fabian J Theis,et al. Generalizing RNA velocity to transient cell states through dynamical modeling , 2019, Nature Biotechnology.
[43] Naftali Kaminski,et al. Single Cell RNA-seq reveals ectopic and aberrant lung resident cell populations in Idiopathic Pulmonary Fibrosis , 2019, bioRxiv.
[44] Jonathan A. Kropski,et al. Single-cell RNA-sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis , 2019, bioRxiv.
[45] C. Ponting,et al. Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.
[46] P. Benos,et al. Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis , 2019, European Respiratory Journal.
[47] J. Hornberg,et al. Use of precision cut lung slices as a translational model for the study of lung biology , 2019, Respiratory Research.
[48] Fabian J. Theis,et al. The Human Lung Cell Atlas - A high-resolution reference map of the human lung in health and disease. , 2019, American journal of respiratory cell and molecular biology.
[49] A. Shilatifard,et al. Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.
[50] E. Matteson,et al. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease. , 2019, American journal of physiology. Lung cellular and molecular physiology.
[51] M. Lindner,et al. Generation of Human 3D Lung Tissue Cultures (3D-LTCs) for Disease Modeling. , 2019, Journal of visualized experiments : JoVE.
[52] Vincent A. Traag,et al. From Louvain to Leiden: guaranteeing well-connected communities , 2018, Scientific Reports.
[53] J. Huggins,et al. Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON. , 2019, The Lancet. Respiratory medicine.
[54] Yiguo Zhang,et al. Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases. , 2018, Toxicology and applied pharmacology.
[55] I. Noth,et al. PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production , 2018, Science Translational Medicine.
[56] M. Lindner,et al. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis , 2018, Respiratory Research.
[57] Kerstin B. Meyer,et al. Fast Batch Alignment of Single Cell Transcriptomes Unifies Multiple Mouse Cell Atlases into an Integrated Landscape , 2018, bioRxiv.
[58] Lucas Pelkmans,et al. Multiplexed protein maps link subcellular organization to cellular states , 2018, Science.
[59] M. Königshoff,et al. The WNT signaling pathways in wound healing and fibrosis. , 2018, Matrix biology : journal of the International Society for Matrix Biology.
[60] Samuel L. Wolock,et al. Scrublet: computational identification of cell doublets in single-cell transcriptomic data , 2018, bioRxiv.
[61] Matthew D. Young,et al. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data , 2018, bioRxiv.
[62] Fabian J Theis,et al. SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.
[63] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[64] M. Lindner,et al. An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[65] J. Aerts,et al. SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.
[66] Yuan Zhang,et al. Association of serum levels of laminin, type IV collagen, procollagen III N-terminal peptide, and hyaluronic acid with the progression of interstitial lung disease , 2017, Medicine.
[67] M. Ebina. Pathognomonic remodeling of blood and lymphatic capillaries in idiopathic pulmonary fibrosis. , 2017, Respiratory investigation.
[68] J. Marioni,et al. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts , 2016, Genome Biology.
[69] Hiroki R Ueda,et al. Whole-body and Whole-Organ Clearing and Imaging Techniques with Single-Cell Resolution: Toward Organism-Level Systems Biology in Mammals. , 2016, Cell chemical biology.
[70] Alexander Pautsch,et al. Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis , 2015, European Respiratory Journal.
[71] N. Tan,et al. Angiopoietin-like 4 Increases Pulmonary Tissue Leakiness and Damage during Influenza Pneumonia , 2015, Cell Reports.
[72] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.
[73] A. Joyner,et al. Sonic hedgehog signaling in the lung. From development to disease. , 2015, American journal of respiratory cell and molecular biology.
[74] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[75] B. Denard,et al. Sustained Induction of Collagen Synthesis by TGF-β Requires Regulated Intramembrane Proteolysis of CREB3L1 , 2014, PloS one.
[76] Shih-Yin Chen,et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. , 2014, The Lancet. Respiratory medicine.
[77] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[78] S. Rosselot. Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[79] F. Martinez,et al. MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis – Validation of Two Novel Biomarker Assays , 2013, PloS one.
[80] Ivana V. Yang,et al. Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis , 2013, Thorax.
[81] D. Schwartz,et al. The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium , 2013, PloS one.
[82] C. Vancheri,et al. Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms , 2011, PloS one.
[83] B. Ryffel,et al. IL-1 and IL-23 Mediate Early IL-17A Production in Pulmonary Inflammation Leading to Late Fibrosis , 2011, PloS one.
[84] E. B. Meltzer,et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44 , 2011, The Journal of experimental medicine.
[85] S. Sahn,et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials , 2011, The Lancet.
[86] W. Tourtellotte,et al. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. , 2011, Matrix biology : journal of the International Society for Matrix Biology.
[87] T. Thatcher,et al. PPAR-γ Ligands Repress TGFβ-Induced Myofibroblast Differentiation by Targeting the PI3K/Akt Pathway: Implications for Therapy of Fibrosis , 2011, PloS one.
[88] Arthur S Slutsky,et al. Activating transcription factor 3 confers protection against ventilator-induced lung injury. , 2010, American journal of respiratory and critical care medicine.
[89] T. Wynn,et al. Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent , 2010, The Journal of experimental medicine.
[90] W. Seeger,et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. , 2009, The Journal of clinical investigation.
[91] W. Seeger,et al. Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis , 2008, PloS one.
[92] T. Wynn,et al. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. , 2007, The Journal of clinical investigation.
[93] Laura Leung,et al. Deficiency of the Nrf1 and Nrf2 Transcription Factors Results in Early Embryonic Lethality and Severe Oxidative Stress* , 2003, Journal of Biological Chemistry.
[94] R. Silver,et al. Thrombin Differentiates Normal Lung Fibroblasts to a Myofibroblast Phenotype via the Proteolytically Activated Receptor-1 and a Protein Kinase C-dependent Pathway* , 2001, The Journal of Biological Chemistry.
[95] N. Goldsack,et al. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. , 2001, The American journal of pathology.